Ipamorelin

Ipamorelin is a synthetic pentapeptide belonging to the class of growth hormone secretagogues (GHS). It functions as a selective agonist of the ghrelin receptor (GHSR-1a), stimulating the release of growth hormone from the anterior pituitary in laboratory research models.

The peptide was originally developed in the 1990s during research into compounds capable of increasing endogenous growth hormone signalling. Compared with earlier growth hormone-releasing peptides, Ipamorelin demonstrates high receptor selectivity, meaning it primarily stimulates growth hormone release without significantly activating other hormone pathways.

In research settings, Ipamorelin is often investigated for its role in growth hormone and IGF-1 signalling pathways, metabolic regulation, and tissue repair mechanisms.

Ipamorelin Peptide Benefits in Research

Ipamorelin peptide benefits are commonly explored in experimental models investigating:
Increases natural growth hormone production
Promotes fat loss and lean muscle development
Enhances sleep quality and recovery
Supports anti-aging and regenerative functions
These findings reflect research observations and are not medical claims.

Research Areas of Interest
Growth hormone signalling pathways
IGF-1 axis research
Endocrine system regulation
Cellular repair and recovery pathways
Metabolic and body composition research
Product Information
Peptide: Ipamorelin
Class: Growth hormone secretagogue (GHS)
Length: 5 amino acids (pentapeptide)
CAS: 170851-70-4
Half-life: ~2 hours
Form: Lyophilised powder
Purity: ≥98% (HPLC tested)
Why Researchers Choose Ipamorelin Peptides
Researchers choose Ipamorelin peptides due to:

Selective GH receptor activity
Minimal reported impact on cortisol and prolactin in research models
Stable lyophilised format
Compatibility with other growth hormone research protocols